Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
The Lancet. Respiratory medicine (2021) - Comments
doi: 10.1016/s2213-2600(20)30558-0  issn: 2213-2600  pubmed: 33422263  issn: 2213-2619 

Jordana B Cohen, Thomas C Hanff, Preethi William, Nancy Sweitzer, Nelson R Rosado-Santander, Carola Medina, Juan E Rodriguez-Mori, Nicolás Renna, Tara I Chang, Vicente Corrales-Medina, Jaime F Andrade-Villanueva, Alejandro Barbagelata, Roberto Cristodulo-Cortez, Omar A Díaz-Cucho, Jonas Spaak, Carlos E Alfonso, Renzo Valdivia-Vega, Mirko Villavicencio-Carranza, Ricardo J Ayala-García, Carlos A Castro-Callirgos